Search clinical trials for: Placebo for TransCon CNP

Total 2696 results

Ascendis Pharma A/S

Active, not recruiting

A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia

Achondroplasia

China
Ascendis Pharma Growth Disorders A/S

Active, not recruiting

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia (ApproaCH)

Achondroplasia

United States, Denmark, Ireland, New Zealand, Australia, Canada, Spain
Ascendis Pharma A/S

Active, not recruiting

A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia

Achondroplasia

United States, Australia, Austria, Denmark, Germany, Ireland, New Zealand, Portugal
Ascendis Pharma Growth Disorders A/S

Enrolling by invitation

A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia (AttaCH)

Achondroplasia

United States, Australia, Denmark, Ireland, Austria, Germany, New Zealand
Ascendis Pharma A/S

Active, not recruiting

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism (PaTH Forward)

Endocrine System Diseases | Parathyroid Diseases | Hypoparathyroidism

United States, Canada, Denmark, Germany, Italy, Norway
Concert Pharmaceuticals

Completed

Multiple Ascending Dose Study in Healthy Volunteers

Healthy

Australia
Concert Pharmaceuticals

Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects

Healthy

Australia
Concert Pharmaceuticals

Completed

A Safety and Tolerability Study of CTP-730 in Healthy Volunteers

Healthy

Australia
Visen Pharmaceuticals (Shanghai) Co., Ltd.

Recruiting

PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism

Endocrine System Diseases | Parathyroid Diseases | Hypoparathyroidism | Parathyroid Hormone Deficiency

China
Ascendis Pharma Bone Diseases A/S

Active, not recruiting

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism (PaTHway)

Endocrine System Diseases | Parathyroid Diseases | Hypoparathyroidism

United States, Canada, Norway, Denmark, Germany, Hungary, Italy
Visen Pharmaceuticals (Shanghai) Co., Ltd.
Ascendis Pharma A/S

Unknown

Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

Endocrine System Diseases | Pituitary Diseases | Growth Hormone Deficiency | Hormones | Pituitary Disease, Anterior

China
Coherent Biopharma (Hefei) Co., Ltd.

Recruiting

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Cancer, Breast | Cancer of Pancreas | Cancer Colorectal | Cancer, Lung | Cancer of Esophagus

China, United States
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis

Rheumatoid Arthritis

Canada, Russian Federation
COUR Pharmaceutical Development Company, Inc.

Not yet recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

Myasthenia Gravis | Generalized Myasthenia | AChR Myasthenia Gravis | MuSK MG

United States
COUR Pharmaceutical Development Company, Inc.

Terminated

CNP-201 in Subjects With Peanut Allergy

Peanut Allergy

United States
COUR Pharmaceutical Development Company, Inc.

Terminated

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy

Peanut Allergy

United States
COUR Pharmaceutical Development Company, Inc.

Active, not recruiting

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States
KU Leuven

Completed

Technical Accuracy and Userfriendliness of a Point-Of-Care C Reactive Protein Device in a Nursing Home Setting

Healthy Older Adults | Ill Older Adults

Belgium
Centre Hospitalier Universitaire, Amiens

Withdrawn

Evaluation of the Contribution of the Ultrasound Tracking and the Positioning of the Distal End During the Implantation of Implantable Chamber or Long-lasting Venous Catheter (EchoPAC)

Echocardiography | Implantable Chamber

France
University Hospital of Split

Not yet recruiting

Diagnostic Importance of the C-reactive Protein From Blood and Saliva in Children With Acute Appendicitis

Acute Appendicitis
Concert Pharmaceuticals

Completed

Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656

Healthy

Australia
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI); Solving Kids' Cancer; Ty Louis Campbell Foundation and other collaborators

Active, not recruiting

Phase I Study of APX005M in Pediatric CNS Tumors

Glioblastoma Multiforme | Medulloblastoma | High-grade Astrocytoma NOS | CNS Primary Tumor, Nos | Ependymoma, NOS | Diffuse Intrinsic Pontine Gliomas (DIPG)

United States
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections

Acute Upper Respiratory Infections

Russian Federation
RAND
Makerere University; Rays of Hope Hospice Jinja; African Palliative Care Association and other collaborators

Not yet recruiting

Game Changers for Cervical Cancer Prevention (GC-CCP)

Cervical Cancer
Oregon Research Institute

Completed

Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse (CAP)

Cannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate

United States
Children's Hospital of Philadelphia
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

School Climate and Children's Behavioral Health (Project Access)

Consultation (LLS) | Consultation and Coaching (HLS)

United States
TenNor Therapeutics (Suzhou) Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants

Helicobacter Pylori Infection

China
JW Pharmaceutical

Completed

Therapeutic Exploratory Study of CWP-0403

Type 2 Diabetes Mellitus

Korea, Republic of
Azienda Ospedaliera Universitaria Senese
Azienda Ospedaliera Niguarda Cà Granda; Azienda USL 1 Imperiese

Unknown

EMR-C VS EMR-S in Colonic Lateral Spreading Tumors Treatment (LST) (LST)

Endoscopic Mucosal Resection

Italy
TenNor Therapeutics (Suzhou) Limited

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection

Helicobacter Pylori Infection

China
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
University of Michigan

Terminated

Brain Computer Interfaces (Mu Rhythm Learning)

Mobility Impairments

United States
Sorbent Therapeutics

Unknown

Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects (STEPWISE)

Heart Failure

Israel, Argentina, United States
Children's Hospital Medical Center, Cincinnati
Verizon Foundation; Luther Foundation

Completed

Improving Asthma Care by Partnering With School Nurses to Bring Asthma Care Into the Inner-City Schools (AFS4)

Asthma

United States
University of Missouri-Columbia

Completed

Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study (SPIN-CWP)

Chronic Widespread Pain | Chronic Insomnia

United States
Tufts University
United States Army Research Institute of Environmental Medicine

Completed

Healthy Families Healthy Forces Study (HF2)

Obesity | Overweight

United States
Sorbent Therapeutics
Pharmaterra

Completed

Evaluation of CLP in Heart Failure Patients With Chronic Kidney Disease

Heart Failure

Georgia, Moldova, Republic of, Armenia
Uppsala University

Unknown

Bone Forming at Prosthetic Surfaces. Fingerprint2

Osteo Arthritis

Sweden
Rhode Island Hospital

Completed

The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU

Delirium

United States
China Medical University Hospital
National Science and Technology Council, Taiwan

Recruiting

NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia

Schizophrenia

Taiwan
China Medical University Hospital
National Science and Technology Council

Recruiting

NMDA Receptor Modulation for the Treatment of Bipolar I Disorder

Bipolar I Disorder

Taiwan
Clene Nanomedicine
Clene Australia Pty Ltd

Terminated

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis (VISIONARY-MS)

Relapsing Remitting Multiple Sclerosis | Optic Neuropathy | Optic; Neuritis, With Demyelination

United States, Canada, Australia
Cephalon

Terminated

Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women

Osteoporosis | Bone Loss

Australia
Ferrer Internacional S.A.

Not yet recruiting

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)

Progressive Supranuclear Palsy
China Medical University Hospital
National Health Research Institutes, Taiwan

Recruiting

Monotherapy of an NMDA Enhancer for Schizophrenia

Schizophrenia

Taiwan
Concert Pharmaceuticals

Completed

A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Clene Nanomedicine
Clene Australia Pty Ltd

Completed

Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS) (RESCUE-ALS)

Amyotrophic Lateral Sclerosis

Australia
Suzhou Connect Biopharmaceuticals, Ltd.
Tigermed Consulting Co., Ltd; Nucleus Network Ltd

Completed

Phase 1 Study Accessing the Safety and Tolerability of CBP-307

Autoimmune Diseases

Australia

Search clinical trials for: Placebo for TransCon CNP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations